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Abstract 22 
The common feature of flaviviral infection is the accumulation of abundant virus-23 
derived noncoding RNA, named flaviviral subgenomic RNA (sfRNA) in infected cells. 24 
This RNA represents a product of incomplete degradation of viral genomic RNA by the 25 
cellular 5’-3’ exoribonuclease XRN1 that stalls at the conserved highly structured 26 
elements in the 3’ untranslated region (UTR). This mechanism of sfRNA generation 27 
was discovered a decade ago and since then sfRNA has been a focus of intense 28 
research. The ability of flaviviruses to produce sfRNA was shown to be evolutionary 29 
conserved in all members of Flavivirus genus. Mutations in the 3’UTR that affect 30 
production of sfRNAs and their interactions with host factors showed that sfRNAs are 31 
responsible for viral pathogenicity, host adaptation, and emergence of new pathogenic 32 
strains. RNA structural elements required for XRN1 stalling have been elucidated and 33 
the role of sfRNAs in inhibiting host antiviral responses in arthropod and vertebrate 34 
hosts has been demonstrated. Some molecular mechanisms determining these 35 
properties of sfRNA have been recently characterized, while other aspects of sfRNA 36 
functions remain an open avenue for future research. In this review we summarize the 37 
current state of knowledge on the mechanisms of generation and functional roles of 38 
sfRNAs in the life cycle of flaviviruses and highlight the gaps in our knowledge to be 39 
addressed in the future. 40 
  41 
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1. Introduction 42 
Flaviviruses have the unique ability to subvert host RNA degradation machinery 43 
for production of virus-derived noncoding RNA (subgenomic flaviviral RNA or sfRNA). 44 
This RNA was found to be produced by all flaviviruses tested to date (Pijlman et al., 45 
2008; MacFadden et al., 2018). It is shown to  inhibit host antiviral response and is 46 
required for viral pathogenicity (Pijlman et al., 2008; Esther Schnettler et al., 2012; 47 
Schuessler et al., 2012). In this review we summarise the available information on the 48 
structural determinants and molecular processes of sfRNA biogenesis in different 49 
ecological groups of flaviviruses, mechanisms behind the inhibitory effect of sfRNA on 50 
host antiviral response in arthropod and vertebrate hosts and discuss the role of 51 
sfRNA in evolution of flaviviruses. We also identify gaps in the current knowledge 52 
about sfRNA functions that are yet to be addressed to fully understand interactions 53 
between sfRNA, other viral processes, and host antiviral defence. 54 
 55 
2. Diversity of genus Flavivirus 56 
Flavivirus genus can be divided into several ecological groups: mosquito-borne 57 
flaviviruses (MBFs) that circulate between mosquito and vertebrates (avian, equine or 58 
human) hosts; tick-borne flaviviruses (TBFs) that are maintained in tick-vertebrate 59 
cycle; viruses that only infect vertebrates and are thought to be transmitted horizontally 60 
between vertebrates (no known vector flaviviruses, NKVFs), and insect-specific 61 
flaviviruses (ISFs) that infect mosquitoes and sand flies and are maintained in vertical 62 
transmission cycles (Blitvich and Firth, 2015). Arthropod-borne flaviviruses (ABFs, 63 
consisting of MBFs and TBFs) is the group of viruses that includes all human 64 
pathogens and until recently was the most studied group. However, other ecological 65 
groups of flaviviruses, and particularly ISFs, have recently attracted significant 66 
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attention due to their ability to inhibit replication of ABFs in co-infected mosquitoes and 67 
their potential use as agents of biocontrol (Bolling et al., 2012; Hall-Mendelin et al., 68 
2016; Hobson-Peters et al., 2013). They are also considered to be a safe platform to 69 
generate recombinant vaccine candidates against pathogenic flaviviruses (Piyasena et 70 
al., 2017). Due to the medical importance of pathogenic flaviviruses, this group of 71 
viruses has been extensively studied and to date we have accumulated a wealth of 72 
knowledge on their ecology, molecular biology and processes involved in antiviral 73 
immunity and virus-host interactions.  74 
 75 
3. Genome of flaviviruses and their 3’UTR 76 
All flaviviruses have a relatively small genome of approximately 11kb in length, 77 
which has one large open reading frame (ORF) (Brinton, 2013). Organisation of 78 
flavivirus genome is schematically represented in Fig 1A.  Genomic RNA of 79 
flaviviruses has type I cap at the 5’-end (Ray et al., 2006) and lacks ploy(A)-tail at the 80 
3’-end (Brinton et al., 1986). ORF encodes for 3 structural (C, PrM and E) and 7 non-81 
structural (NS1, NS2A, NS2B, NS3, NS4A, NS4B and NS5) proteins (Chambers et al., 82 
1990). Structural proteins form viral particles, whereas non-structural proteins are 83 
involved in viral RNA replication and inhibition of host antiviral response (reviewed in 84 
(Roby et al., 2012)). Viral ORF is translated as a single polyprotein, which is cleaved 85 
into mature proteins by viral and host proteases. Cleavage at most sites occurs co-86 
translationally except prM/E junction, which is cleaved post-translationally (Lobigs M., 87 
1993). Viral ORF is flanked by 5’ and 3’-untranslated regions (UTRs) that are required 88 
for replication of the viral genome (Khromykh et al., 2001; Ng et al., 2017) and 89 
translation of viral polyprotein (Holden & Harris, 2004; Chiu et al., 2005). 3’UTRs of all 90 
MBFs have conserved secondary structure (Fig 1B) and contain duplicated stem loop 91 
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elements (SLs) followed by one or two dumbbell structures (DBs) and terminal 3’-stem 92 
loop (3’SL) preceded by a short hairpin (sHP) (Clarke et al., 2015). Due to the complex 93 
secondary and tertiary structure, 3’UTRs of flaviviruses are resistant to digestion by 94 
the host 5’-3’ exoribonuclease XRN-1 - the enzyme responsible for degradation of 95 
uncapped host and viral RNAs in the cytoplasm (Funk et al., 2010; Pijlman et al., 96 
2008). This resistance prevents complete degradation of flaviviral genomes and 97 
results in accumulation of the abundant RNA fragments derived from the 3’UTR in 98 
infected cells (Fig. 1B,C) (Pijlman et al., 2008). These viral RNA species, referred as 99 
sfRNAs, were shown to be produced in arthropod and vertebrate hosts by all 100 
flaviviruses tested to date (Chapman et al., 2014; MacFadden et al., 2018; Pijlman et 101 
al., 2008) and to be required for viral pathogenesis and evasion of host antiviral 102 
response (reviewed in (Clarke et al., 2015; Roby et al., 2014)). The unique ability of 103 
flaviviruses to utilize host RNA degradation pathway for production of viral 104 
pathogenicity factor and the important functions of sfRNA in flavivirus life cycle 105 
attracted significant interest in recent years. This has led to rapid advance in our 106 
understanding of molecular mechanisms of sfRNA biogenesis and different functions 107 
of sfRNA as well as provided new insights into potential roles of sfRNA in flavivirus 108 
evolution and host adaptation. 109 
 110 
4. Mechanism of sfRNA biogenesis. 111 
4.1. sfRNA is produced as a product of incomplete degradation of viral 112 
genomic RNA by the host exoribonuclease XRN-1. 113 
 Similar to cellular RNAs, genomic RNA of flaviviruses can become a subject to 114 
degradation by the host mRNA decay machinery. Eukaryotic RNA degradation 115 
machinery consists of coordinated endo- and exoribonucleases and multiple auxiliary 116 
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factors (reviewed in (Garneau et al., 2007; Houseley and Tollervey, 2009)). It acts to 117 
maintain the balance of cellular mRNAs, prevents translation of aberrant transcripts 118 
and protects cells from exogenous infectious RNAs. As most cellular mRNA are 119 
capped and polyadenylated, these RNA modifications serve as primary markers for 120 
RNA quality surveillance and determine the fate of cellular transcripts (Bernstein et al., 121 
1989; Gao et al., 2000). Removal of either cap or poly(A)-tail is required to trigger 122 
exonucleolytic mRNA degradation pathways. Deadenylation, which results from either 123 
the enzyme activity of deadenylase or the edonucleolytic cleavage by nucleases such 124 
as RNaseL and Ago, is usually the first step in eukaryotic mRNA decay (Schoenberg 125 
and Maquat, 2012). RNAs lacking poly(A)-tail can be subjected to degradation by 3’ -> 126 
5’ exoribonucleases in the multi-subunit RNA degradation complexes called exosomes 127 
(Decker and Parker, 1993). In addition, deadenylation triggers decapping of mRNAs 128 
and their degradation in 5’ -> 3’ direction by exoribonuclease 1 (XRN-1) (Tomecki and 129 
Dziembowski, 2010), which is believed to be the major mRNA decay pathway in 130 
eukaryotes (Garneau et al., 2007). Removal of the cap structure from cytosolic RNAs 131 
is catalysed by decapping enzymes DCP1/DCP2 and involves a number of other 132 
cofactors (Liu et al., 2002). XRN-1 recognises decapped RNA as they possess 5’-133 
monophosphate, which interacts with a positively charged pocket in XRNA-1 molecule. 134 
XRN-1 then unwinds target RNA due to its ATP-dependent RNA-helicase activity and 135 
rapidly digests bound RNAs by removing nucleotides from the 5’-end one by one 136 
generating no intermediate products (Jinek et al., 2011). Enzymes required for 5’ -> 3’ 137 
RNA decay such as XRN-1 and decapping proteins are localized in the cytoplasm and 138 
can assemble into multiprotein granular formation called P-bodies or stress granules. 139 
Assembly of P-bodies is often triggered by stress conditions associated with 140 
accumulation of large amounts of RNA subjected to degradation, including RNA virus 141 
infection (Lloyd, 2013). 142 
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At the 5’-end genomic RNA of flaviviruses contains a cap structure with a 143 
methyl groups in position N7 and at the 2’OH position of ribose of the first nucleotide 144 
(type I or m(7)GpppAmN cap) (Ray et al., 2006). The 3’-end of the viral genome does 145 
not have poly(A)-tail and terminates with a stem loop structure (3’SL), which is very 146 
conserved among all flaviviruses and has high thermodynamic stability (Dong et al., 147 
2008). Interestingly, cellular mRNAs encoding for histones are also lacking poly(A) and 148 
contain 3’ terminal stem loop (Zanier et al., 2002). This stem loop protects histone 149 
mRNAs from 3’ -> 5’ digestion via interaction with stem loop binding protein (SLBP) 150 
(Williams and Marzluff, 1995) and degradation of these mRNAs primarily occurs via 5’ 151 
-> 3’ mechanism dependent on 3’-oligouridylation. 3’SL of flaviviruses is also believed 152 
to protect viral RNA from 3’ -> 5’ exoribonucleases and determines RNA stability 153 
despite the lack of poly(A)-tail (Ford and Wilusz, 1999). However, it is currently 154 
unknown if 3’SL of flaviviruses has the same role as 3’SL of histone mRNA. Protection 155 
of 3’-end from 3’ -> 5’ degradations by 3’SL implies that endonucleolytic cleavage by 156 
RNase L  (Samuel et al., 2006; Scherbik et al., 2006) and 5’ -> 3’ degradation by XRN-157 
1 are likely to be the predominant pathways for flaviviral genomic RNA decay 158 
(Narayanan and Makino, 2013). However, flaviviruses evolved to block complete 159 
degradation of viral genomic RNA by XRN-1 at the beginning of 3’UTR in order to 160 
produce functional noncoding RNA. 161 
Production of sfRNA by flaviviruses was first reported for MVEV (Urosevic et al., 162 
1997) and later shown to be a common characteristics for flaviviruses in general. All 163 
ABFVs (Akiyama et al., 2016; Lin et al., 2004; Pijlman et al., 2008) and also recently 164 
ISFs and NKVFVs (MacFadden et al., 2018) have been shown to generate sfRNA. 165 
Biogenesis of sfRNA as XRN-1 dependent process (Fig 1B) was first described by our 166 
group for WNV in 2008 (Pijlman et al., 2008). Using recombinant constructs in which 167 
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genomic RNA of WNV with various deletions was transcribed from CMV promoter, we 168 
demonstrated that sfRNA is produced independently of virus replication and of viral 169 
proteins. We hypothesised that sfRNA is generated as the result of incomplete 170 
digestion of viral genomic RNA by XRN-1 and confirmed this hypothesis by 171 
demonstrating decreased production of WNV sfRNA in XRN-1-depleted cells, co-172 
localization of XRN-1 with WNV sfRNA in infected cells, and the ability of XRN-1 to 173 
convert viral genomic RNA into sfRNA in vitro (Pijlman et al., 2008). Later the role of 174 
XRN-1 in generation of sfRNA was confirmed for other ABFs such as YFV (Silva et al., 175 
2010), DENV (Chapman et al., 2014a) and ZIKV (Akiyama et al., 2016), as well as for 176 
ISFV Cell Fusion Agent Virus (CFAV) (MacFadden et al., 2018) and several NKVFs 177 
(MacFadden et al., 2018). 178 
We determined that the 5’-end of WNV sfRNA aligns with the SL-II structure 179 
within WNV 3’UTR (Pijlman et al., 2008). Deletion or disruption of this structure by 180 
mutagenesis abolished generation of full-length sfRNA, indicating that SL-II was 181 
required for stalling XRN-1 and producing sfRNA. In addition, three smaller sfRNA 182 
species were detected in cells infected with WNV showing that downstream SL-IV and 183 
possibly dumb bell structures could also have the ability to stall XRN-1 (Funk et al., 184 
2010; Pijlman et al., 2008). Later, using higher resolution gels, these smaller sfRNAs 185 
(named sfRNA-2, sfRNA-3, and in some cases sfRNA4) were shown to be also 186 
produced in cells infected with different flaviviruses (Fig 1C for DENV2) (Akiyama et 187 
al., 2016; Chapman et al., 2014a; Filomatori et al., 2017), indicating that in some 188 
instances XRN-1 can “slip” through the first resistant structure and stall at the 189 
downstream structural elements. Two sfRNA species has been also detected in YFV-190 
infected mammalian cells, however sfRNA-2 of YFV had the same 5’end as sfRNA-1 191 
and was truncated by ~100nts at the 3’end (Silva et al., 2010). The mechanism that 192 
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determines generation of sfRNA-2 by YFVs has not yet been characterized and 193 
production of 3’-truncated sfRNA has not been reported for other flaviviruses.   194 
4.2. Structural determinants of sfRNA biogenesis are unique tertiary RNA 195 
structures that differ between phylogenetic groups of flaviviruses. 196 
4.2.1. Secondary and tertiary structures of XRN-1 resistant elements in 197 
MBFVs 198 
Currently two classes of XRN-1 resistant elements (xrRNAs) have been 199 
identified in 3’UTRs of MBFVs – xrRNAs formed by stem loops (SL) and those that 200 
involve dumb bell (DB) structures (Fig. 2A) (Funk et al., 2010). All mosquito-borne 201 
flaviviruses tested to date have been shown to contain at least one xrRNA (Clarke et 202 
al., 2015). YFV seem to have the simplest set of xrRNAs with only one SL (SLA) and 203 
one DB (SLB) (Silva et al., 2010), but  majority of MBFs have duplicated XRN-1-204 
resistant elements (Villordo et al., 2016). ZIKV, for instance, has two SLs (SL1, SL2), 205 
and one DB (Akiyama et al., 2016), Rocio virus is predicted to have one SL (SL1) and 206 
two DB (DB1, DB2) structures (Setoh et al., 2018) and WNV and DENV have 207 
duplication of both – SLs (SLII and SLIV for WNV, SLI and SLII for DENV) and DBs 208 
(DBI, DBII) (Filomatori et al., 2017; Funk et al., 2010). These elements are usually 209 
designated as xrRNAs 1 to 4 (in 5’ to 3’ direction) and are required for production of 210 
sfRNAs 1 to 4, respectively, with sfRNA-1 being the longest (Fig 1B,C).  211 
XRN-1 is a highly processive enzyme that has an RNA-helicase activity and is 212 
generally capable of digesting structured RNAs. When the ability of SLII, SLIV and DBI 213 
of WNV 3’UTR to stall XRN-1 was discovered, only the homopolymer G stretches of 214 
9+ nucleotides were known to efficiently halt RNA digestion by XRN-1, whereas stem 215 
loops were thought to have very little effect on processivity of 5’ -> 3’ exoribonucleases 216 
(Poole and Stevens, 1997). It was therefore puzzling why stem loops within the 217 
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faviviral genomes have such a dramatic effect on XRN-1 processing and at the same 218 
time do not interfere with viral polymerase moving in 3’ to 5’ direction on the viral 219 
template (+) RNA strand while synthesising (-) RNA strand. It was hypothesised that 220 
stem loops of flaviviruses must be involved in formation of higher order tertiary 221 
structures to confer XRN-1 resistance (Funk et al., 2010). To address this matter, 222 
secondary and tertiary structures of MBFV 3’UTRs were assessed using 223 
computational folding prediction, enzymatic/chemical RNA structure probing and 224 
mutational analysis (Alvarez et al., 2005; Chapman et al., 2014a; Funk et al., 2010; 225 
Kieft et al., 2015a; Silva et al., 2010). In addition, crystal structures of MVEV and ZIKV 226 
xrRNAs have now been solved (Akiyama et al., 2016; Chapman et al., 2014). 227 
First insights into the structural basis of XRN-1 resistance were provided by our 228 
study (Funk et al., 2010) and the study by Silva et al (Silva et al., 2010). These studies 229 
showed that XRN-1 resistant stem loops of WNV and YFV were involved in 230 
pseudoknot (PK) interactions (Figs 1B and 2A). PKs are RNA structures that contain 231 
two helical segments connected by single-stranded segments or loops. Most common 232 
type of PK is the H-type fold, in which nucleotides in the loop of a hairpin form 233 
intramolecular pairs with nucleotides outside of the stem, which leads to formation of a 234 
second stem and loop and results in a PK with two stems and two loops (Staple and 235 
Butcher, 2005). These type of PKs were shown to be formed between the loop regions 236 
of SLs/DBs of WNV and YFV and the downstream single stranded regions (Fig 2A) 237 
(Chapman et al., 2014a; Funk et al., 2010; Silva et al., 2010). Mutations in either loops 238 
of SLs or the interacting regions outside the SLs that prevented PK formation were 239 
shown to abolish production of corresponding sfRNA molecules, whereas mutations 240 
that didn’t influence base pairing had no effect on the ability of the viruses to produce 241 
sfRNAs (Funk et al., 2010; Silva et al., 2010). Importantly, compensatory mutations 242 
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restoring PK interactions also restored XRN-1 resistance and generation of sfRNAs 243 
(Funk et al., 2010; Silva et al., 2010).  Recently, similar PK-interactions were also 244 
demonstrated to confer XRN-1 resistance of xrRNAs in ZIKV(Akiyama et al., 2016). 245 
However, somewhat different results were obtained when the ability of DENV 246 
SLs to form pseudoknots was tested by chemical probing (Chapman et al., 2014). 247 
Despite SLI of DENV (equivalent of WNV SLII) was predicted to be involved in PK-248 
formation by computational analysis, chemical structure probing revealed that both 249 
RNA segments expected to interact were most likely unpaired (Chapman et al., 250 
2014a). In addition, mutations that were predicted to prevent formation of PK were 251 
shown to reduce, but not completely abolish production of DENV sfRNA-1 (Filomatori 252 
et al., 2017). For DENV SLII (equivalent of WNV SLIV), PK-interactions were 253 
confirmed, however elimination of this interactions by mutations only reduced 254 
production of sfRNA-2 by less than 50% (Chapman et al., 2014a). These observations 255 
led to the conclusion that PK interactions could be rather transient and not always 256 
crucial for stalling XRN-1 (Chapman et al., 2014a; Kieft et al., 2015a). 257 
Recently crystal structures of xrRNA-2 of MVEV (Chapman et al., 2014) and of 258 
xrRNA-1 of ZIKV (Akiyama et al., 2016) have been solved (Fig 2B), which has become 259 
a turning point in our understanding of the structural basis of XRN-1 resistance and 260 
sfRNA biogenesis. The structural analysis revealed that both xrRNA1 and xRNA2 form 261 
three-way junctions with coaxial stacking of helices P1 and P2, while helix P3 262 
positioned at the acute angel to P1 (Fig 2B). Three-way junctions are structural 263 
elements of “branched” nucleic acids in which three double helical arms are connected 264 
at the junction point, with or without several unpaired bases in one or more of the three 265 
different strands (Lilley, 1998). Three-way junctions are common in highly structured 266 
nucleic acids such as rRNA and hammerhead ribozymes (Lilley, 1998). They can 267 
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acquire three major types of topology and usually involve formation of non-canonical 268 
base pairs such as base triplices and Hoogsteen hydrogen bonds (Lescoute, 2006). 269 
Surprisingly, three-way junctions that are formed in xrRNAs of MVEV and ZIKV have 270 
the unique topology that have not been previously observed in any other RNAs and 271 
cannot be classified into any of 3 known types of three-way junctions. They acquire the 272 
conformation in which 5’-end of the RNA passes through a ring-like structure (Fig 2B), 273 
which is somewhat similar to a knot (Akiyama et al., 2016; Chapman et al., 2014). The 274 
most likely model that explains XRN-1 resistance for this unusual fold suggests that 275 
the ring-like structure creates a mechanical block for XRN-1 (MacFadden et al., 2018). 276 
This model is based on the crystal structure of xrRNAs (Akiyama et al., 2016; 277 
Chapman et al., 2014) and the experiments in which the resistance of xrRNAs to a 278 
range of exonucleases unrelated to XRN-1 was tested (MacFadden et al., 2018). It 279 
assumes that the ring surrounding 5’ end of RNA braces against the surface of the 280 
enzyme around the active site (Fig 2C) and prevents XRN-1 from assessing the next 281 
nucleotide, which blocks progression of XRN-1 in 5’ to 3’ direction (Fig 2C). The 282 
helicase activity of XRN-1 would not help to overcome this obstruction as the enzyme 283 
would need to pull 5’-end through the structure rather than simply unwind the helix 284 
(Chapman et al., 2014; Kieft et al., 2015a). The enzymes acting in 3’ to 5’ direction do 285 
not encounter this obstacle as they enter the structure from the outside, which explains 286 
why this structure for example does not halt viral RdRP. Formation of the ring-like 287 
topology was shown to require base triples and base pairs between the 5’-end of 288 
xrRNAs and three-way junction, and to be stabilised by a small PK and base pairing 289 
(Watson-Crick and non-canonical) within the junction (Fig 2B). All nucleotides required 290 
for the folding of ring-like structure were shown to be highly conserved amongst 291 
MBFVs (Akiyama et al., 2016). 292 
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PK between the apical loop of xrRNA-forming SL and the downstream 293 
complementary region of UTR was not evident in the crystal structure of MVEV 294 
xrRNA-2 although the RNA regions predicted to form PK were located in close 295 
proximity and ready to pair (Chapman et al., 2014). However, in more recent crystal 296 
structure of ZIKV xrRNA-1, PK was clearly defined (Akiyama et al., 2016). These 297 
results suggest that PKs can be transient and used to stabilise XRN-1 resistant fold 298 
rather than being XRN-1 resistant themselves (Akiyama et al., 2016; Kieft et al., 2015). 299 
Based on the cumulative data from structural and functional studies a model was 300 
proposed that suggests stabilising role of PKs and explains how a complex tertiary 301 
structure with RNA strand threading through the centre of the ring can be formed in the 302 
context of full-length genomic RNA. According to this model, the entire xrRNA 303 
structure is unfolded and ring is open until the 5’-terminal nucleotides of xrRNA pair 304 
with those in three-way junction. Once the pairing occurs, the junction forms around 305 
the 5’-end of xrRNA, causing the single stranded RNA segments of the loop and 306 
downstream region of 3’UTR to move into position where they can interact. As soon as 307 
they appear in the position that allows pairing, the PK is formed and the ring is 308 
“latched” in the stable XRN-1 resistant conformation (Kieft et al., 2015). 309 
Acquisition of high-resolution crystal structures of SL-based MVEV and ZIKV 310 
xrRNAs significantly advanced our understanding of how flaviviruses achieve unique 311 
resistance to 5’->3’ exonucleolytic digestion. However, the structural basis of XRN-1 312 
resistance in DB structures, predicted to be responsible for generation of shorter 313 
sfRNA species, remains to be determined. 314 
4.2.3. XRN-1 resistant elements in insect-specific flaviviruses (ISFs) 315 
ISFs are phylogenetically heterogeneous group of flaviviruses that can only 316 
replicate in mosquitoes and are maintained via vertical transmission. Their ability to 317 
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produce sfRNA has not been tested until recently (MacFadden et al., 2018) and the 318 
structural determinants of XRN-1 resistance have not been well characterized. Current 319 
knowledge about sfRNA biogenesis in ISFs is based on the chemical probing of the 320 
secondary structure in a single flavivirus Cell Fusion Agent Virus (CFAV) (MacFadden 321 
et al., 2018), and predominantly using in silico analyses (MacFadden et al., 2018; 322 
Roby et al., 2014; Villordo et al., 2016). 323 
ISFs can be divided into two phylogeneticaly distinct groups (Fig 2A): 324 
clade/lineage I or classic ISFs and clade/lineage II or dual-host associated ISFs (Hall 325 
et al., 2016). Clade I ISFs are most phylogenetically distinct from ABFVs, are thought 326 
to have evolved to replicate solely in insects, and are likely to represent the ancestors 327 
of all flaviviruses (Hall et al., 2016). In contrast, dual-host associated ISFs display high 328 
degree of sequence similarity to MBFVs and are thought to have diverged from 329 
MBFVs by losing their ability to propagate in vertebrates and adapting to vertical 330 
transmission in mosquitos (Hall et al., 2016). 331 
As Clade II ISFs are very similar to MBFVs with a high degree of homology in 332 
3’UTR, it is expected that they employ mechanisms of sfRNA biogenesis that 333 
resemble those of MBFVs (Villordo et al., 2016). Computational sequence alignment 334 
and secondary structure prediction for Clade II flavivirus Chaoyang Virus (CHAOV) 335 
revealed that 3’UTR of this virus has high structural homology to the 3’UTR of MBFVs 336 
and contain SL and DB structures capable of forming PKs. The SL element of CHAOV 337 
3’UTR also shares with MBFVs the conserved nucleotides in the positions critical for 338 
the formation of the ring-like three-dimensional xrRNA fold (Villordo et al., 2016). It is 339 
therefore believed that Clade II ISFs would produce sfRNA similar to MBFVs utilising 340 
this element as the structural determinant of XRN-1 resistance (Fig 2A) (MacFadden 341 
et al., 2018; Villordo et al., 2016). However, production of sfRNA by Clade II 342 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
 15
flaviviruses has not been experimentally demonstrated and no data exists to support 343 
the XRN1-resistant structures predicted by computer modelling (Villordo et al., 2016). 344 
In contrast to Clade II ISFs, 3’UTRs of viruses from Clade I have very little 345 
sequence and structural similarity to those of MBFVs (Gritsun et al., 2014; Villordo et 346 
al., 2016). Computational prediction revealed that the only structural element shared 347 
between these two groups is the 3’-terminal stem loop (3’SL) (Gritsun et al., 2014). 348 
3’UTRs of Clade I ISFs were also shown to be lacking sequences, that are strictly 349 
conserved in MBFVs xrRNAs. Moreover, Clade I ISFs is a very heterogeneous group 350 
that include three very distinct subgroups: viruses that infect Aedes mosquitos 351 
(AeISFs), Culex-associated viruses (CxISFs), and recently discovered viruses 352 
infecting only Anopheles mosquitoes (AnISFs) (Hall et al., 2016; Insect-specific, 2017). 353 
The first attempt to predict secondary structures within the 3’UTR of Clade I ISFs did 354 
not reveal elements capable of forming high-order structures, but instead 355 
demonstrated the presence of abundant short direct repeats and short hairpins 356 
(Gritsun et al., 2014). Similar results were also obtained in the later finding that 357 
involved secondary structure prediction and estimation of structural similarities based 358 
on tree alignment model (Villordo et al., 2016). This study, however, identified a 359 
putative duplicated structure with a potential to form PK interaction in Aedes-360 
assosiated ISFs CFAV and AEFV (Aedes flavivirus), which could represent a potential 361 
xrRNA structure (Villordo et al., 2016). 362 
Recently, experimental evidence for sfRNA production by CFAV has been 363 
obtained and the secondary structure of the 3’UTR element responsible for XRN-1 364 
stalling has been resolved by chemical probing (MacFadden et al., 2018). Production 365 
of sfRNA in CFAV-infected C6/36 cells was detected by Northern blot. The 5’-end of 366 
CFAV sfRNA was determined by primer extension and found to align with an SL 367 
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structure (Fig 2A). The ability of this structure to resist XRN-1 digestion was 368 
demonstrated in in vitro assay thus confirming that this element is bona fide xrRNA 369 
(MacFadden et al., 2018). Secondary structure of CFAV sfRNA was then determined 370 
by SHAPE analysis and computational folding. It was shown to form three-way 371 
junction and PKs similar to those in MBFV xrRNAs (Fig 2A). The nucleotides at the 5’-372 
end of CFAV xrRNA and in the critical positions of three-way junctions were different 373 
to those found in MBFVs xrRNAs (Fig 2A), but able to form similar base triples and 374 
base pairs. Thus, xrRNA of CFAV was suggested to also fold into a similar ring-like 375 
tertiary structure as xrRNAs of MBFVs despite lacking sequence similarity. In addition, 376 
sequence alignment identified second homologous structure in the CFAV 3’UTR, 377 
suggesting presence of a putative xrRNA-2. MacFadden and co-authors also 378 
demonstrated that nucleotides critical for formation of three-way junction, PK and ring-379 
like structure identified in CFAV xrRNA were conserved between CFAV, Aedes 380 
flavivirus (AeFV) and Kamiti river virus (KRV) and suggested that all Clade I ISFs may 381 
employ similar to CFAV mechanism for sfRNA production (MacFadden et al., 2018). 382 
However, the sequence alignment of MacFadden et al. only included Aedes-383 
associated ISFs - the only Clade I ISFs previously predicted to contain high-order 384 
structures in 3’UTRs (Villordo et al., 2016). The ability of Culex and Anopheles 385 
associated ISFs to produce sfRNA has not yet been tested and the secondary 386 
structures of their 3’UTRs remain either only predicted (CxISFs) or not assessed at all 387 
(AnISFs).  388 
4.2.3. Structural determinants of sfRNA biogenesis in tick-borne and no 389 
known vector flaviviruses. 390 
Tick-born flaviviruses (TBFVs) are another group of dual-host flaviviruses. They 391 
circulate between ticks and vertebrates and include several human pathogens 392 
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(reviewed in (LaSala and Holbrook, 2010)). Together with MBFVs they were among 393 
other flaviviruses demonstrated to produce sfRNA (Pijlman et al., 2008; Schnettler et 394 
al., 2014). TBFVs, however, have 3’UTRs that are rather dissimilar to 3’UTRs of 395 
MBFVs (MacFadden et al., 2018). XRN1-resistant structures in TBFVs were 396 
determined and analysed by chemical probing (Fig 2A) (MacFadden et al., 2018). 397 
They were shown to also contain three-way-junction and PK between apical loop and 398 
downstream 3’UTR sequence (MacFadden et al., 2018; Schnettler et al., 2014). 399 
However, the three-way junction was positioned on a longer stem compared to MBFVs 400 
and sfRNA start site was located in a bulging region within the stem, whereas in 401 
MBFVs it is preceding the stem region. The three-way-junctions in TBFVs could not be 402 
assigned to any known classes and thus their tertiary fold was impossible to predict 403 
without direct structural data (e.g. X-ray crystallography). Interestingly, the PK in 404 
TBFVs xrRNAs was shown to be critically important for XRN-1 resistance and sfRNA 405 
generation by mutational analysis (MacFadden et al., 2018).  406 
No known vector flaviviruses (NKVFVs) are members of Flavivirus genus that 407 
exhibit restriction of replication to vertebrate (rodent or bat) host only (reviewed in 408 
(Blitvich and Firth, 2017)). This is a non-taxonomic group, which includes at least two 409 
phylogenetic subgroups of viruses – one related to MBFVs and one related to TBFVs 410 
(Blitvich and Firth, 2017). The ability of these viruses to produce sfRNA was tested 411 
only recently (Kieft et al., 2015; MacFadden et al., 2018). MBFV-like virus Yokose 412 
virus (YOKV) was found to contain conserved sequences responsible for xrRNA 413 
folding in MBFVs and predicted to have similar to MBFVs structure of 3’UTR (Fig 2A). 414 
It was suggested to be capable for sfRNA production via the same mechanism 415 
employed by MBFVs, but it was not experimentally tested (MacFadden et al., 2018). 416 
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NKVFVs that are similar to TBFVs were recently shown to produce sfRNA in 417 
infected cells (MacFadden et al., 2018). Montana myotis leukoencephalitis virus 418 
(MMLV), Apoi virus (APOIV), Modoc virus (MODV) and Rio Bravo virus (RIBV) were 419 
tested in this study. The 5’-ends of sfRNAs produced by these viruses were 420 
determined and shown to align with the structural elements similar to xrRNAs of 421 
TBFVs (Fig 2A). By the combination of in vitro XRN-1 resistance assay, SHAPE 422 
analysis and mutational study these NKVFVs were shown to contain the same 423 
structural determinants of XRN-1 resistance and sfRNA biogenesis as TBFVs 424 
(MacFadden et al., 2018). 425 
The fact that TBFVs and related NKVFVs produce sfRNA but seem to have 426 
XRN-1 resistant elements different from those of MBFVs emphasizes the importance 427 
of sfRNA in the life cycle of flaviviruses replicating in variety of hosts and indicates that 428 
different groups of flaviviruses may have developed different ways to stall XRN-1. 429 
Crystallisation of xrRNAs for these viruses and generation of structural data is required 430 
to obtain more complete understanding on how they interact with and stall XRN-1 to 431 
generate sfRNAs. 432 
 433 
4.3. Alterations between sfRNA isoforms and host adaptation  434 
The majority of flaviviruses contain duplications of structural elements in the 435 
3’UTR able to resist XRN-1 degradation. These can be SLs, DBs, or both. It has been 436 
known for a while that presence of these duplicated elements results in production of 437 
several sfRNA isoforms with different 5’-ends (sfRNA-1, sfRNA-2, sfRNA-3, etc), 438 
however the functional implications of producing different sfRNA species remained 439 
unclear (Villordo et al., 2016). However, recent studies provided the evidence that 440 
different sfRNA species can be beneficial for flavivirus replication in different hosts and 441 
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that DENV life cycle involves genetic alterations that switch between production of 442 
sfRNA-1 and sfRNA-2 depending on the host virus replicates in (Filomatori et al., 443 
2017; Villordo et al., 2015). DENV contains four putative xrRNA resistant structures 444 
represented by two SLs (SLI and SLII) and two dumb bells (DBI and DBII) and 445 
produces three or four sfRNA species (Kieft et al., 2015). Villordo et al and Filomatori 446 
et al demonstrated that natural populations of DENV include viruses with mutations 447 
within SL-structures of the 3’UTR. Upon infection of mosquitos or passaging in 448 
mosquito cell line, the selective pressure favoured replication of viruses with mutations 449 
in SLII that disrupt xrRNA2. These viruses quickly overpopulated other genotypes and 450 
represented the vast majority of DENV population in mosquitos. In mammalian cells, 451 
however, the opposite effect was observed: viruses with mutations in xrRNA2 induced 452 
stronger type I IFN response and the selective pressure acted against the viruses with 453 
impaired xrRNA2 formation. As the result, viruses with intact SLII quickly became the 454 
majority of DENV population in mammalian host. In addition, they accumulated 455 
mutations that stabilize PK within xrRNA1. Disruption of xrRNA2 was shown to benefit 456 
DENV replication in mosquito cells, whereas presence of both intact xrRNAs was 457 
found to slightly improve viral fitness in mammalian cells (Villordo et al., 2015). These 458 
mutations were shown to alter the patterns of sfRNAs produced by DENV. Viruses 459 
with intact xrRNAs, adapted to mammalian host, were demonstrated to produce 460 
predominantly sfRNA-1, and, to some extent, sfRNA-3. However, mosquito-adapted 461 
viruses with mutations in xrRNA2, had reduced production of longer sfRNA-1 and 462 
sfRNA-2 and generated the abundance of shorter sfRNA-3 and sfRNA-4. Why 463 
mutations in xrRNA2 and not in xrRNA1 result in such profound changes in production 464 
of sfRNA-1 remains unclear. Allegedly, this involves not yet characterized interactions 465 
between SLI and SLII in which SLII stabilizes xrRNA1. Similar sfRNA patterns were 466 
also observed in DENV-infected mosquitos. Based on these observations and 467 
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correlation between sfRNA-1 accumulation and viral fitness in mammalian cells, the 468 
hypothesis was proposed that DENV replication in different hosts requires different 469 
sets of sfRNAs and that SLII/xrRNA2 structure acts as a genetic switch between their 470 
production during alternation between the hosts (Filomatori et al., 2017).  471 
Therefore, it was suggested that duplication of structural elements in 3’UTRs of 472 
flaviviruses occurred in conjunction with transition to the dual-host life cycle to enable 473 
adaptation to switching between the hosts (Kieft et al., 2015; Villordo et al., 2016). 474 
However, further studies are required to validate this assumption as so far 475 
accumulation of adaptive mutations in xrRNA2 leading to switching between different 476 
sets of sfRNA species has only been demonstrated for DENV (Filomatori et al., 2017; 477 
Villordo et al., 2015). ZIKV, on the other hand, was shown to produce the same 478 
patterns of sfRNAs in both, mosquito and mammalian, cells (Filomatori et al., 2017). In 479 
addition, lack of sfRNA-1 was shown not to significantly affect replication of WNV in 480 
mosquitoes and mosquito cell lines, whereas replication of the mutant virus deficient in 481 
both, sfRNA-1 and sfRNA-2, was significantly reduced in mosquito but not in 482 
mammalian cells (Funk et al, 2010; Goertz, 2016). At the same time, production of 483 
sfRNA-1 was shown to be required for WNV pathogenicity in mice (Pijlman 2008, Funk 484 
2010) and for WNV penetration of mosquito gut barrier and virus dissemination into 485 
salivary glands (Göertz et al., 2016). These observations emphasize the importance of 486 
different sfRNA species for replication of ABFVs in different hosts while also 487 
highlighting further need to investigate their role in determining tissue/host-specific 488 
replication, transmission and pathogenesis for each individual virus.  489 
Duplicated SLs capable of folding into xrRNAs have recently been identified in 490 
clade I ISFs CFAV, KRV and AeFV by computational prediction with reference to a 491 
sequence that has experimentally validated structure (MacFadden et al., 2018; Villordo 492 
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et al., 2016). Generation of long sfRNA (sfRNA1) was also demonstrated for ISF 493 
CFAV (MacFadden et al., 2018). It is unclear in the context of the hypothesis 494 
suggesting structure duplications as a mechanism allowing adaptation to different 495 
hosts why viruses that don’t alternate between different hosts also have duplicated 496 
3’UTR structures and predominantly generate sfRNA-1. More detailed and extensive 497 
investigation of the role for different sfRNAs in the context of flavivirus evolution and 498 
virus-host interactions therefore represents important future research direction in this 499 
area. 500 
Another important implication from the studies with host-adapted DENV variants 501 
is a possible role of xrRNA2 in biogenesis of sfRNA-1 (Filomatori et al., 2017). 502 
Previously sfRNA-1 was thought to be produced due to XRN-1 stalling at xrRNA-1 and 503 
this structure was believed to be self-sufficient barrier for XRN-1. However, DENV 504 
mutants with disrupted xrRNA-2 were shown to have impaired production of both 505 
sfRNA species – sfRNA-2 and sfRNA-1. Similar phenomenon was also observed 506 
previously when xrRNA-2 of WNV was mutated (Funk et al., 2010). This opens 507 
another avenue for future studies of the interplay between xrRNAs in sfRNA 508 
biogenesis.  509 
5. Functions of sfRNA 510 
Together with the discovery of mechanism for sfRNA generation, we reported 511 
the requirement of sfRNA for viral pathogenicity (Pijlman et al., 2008). WNV mutants 512 
lacking production of sfRNA1, or sfRNA1 and sfRNA2 were shown to exhibit reduced 513 
pathogenicity in mice (Pijlman et al., 2008). Later studies demonstrated the pivotal role 514 
of sfRNA in replication, dissemination and transmission of a wide range of flaviviruses 515 
(Chang et al., 2013; Donald et al., 2016; Filomatori et al., 2017; Junglen et al., 2017). 516 
In addition, host pathways targeted by sfRNA to facilitate virus replication, 517 
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dissemination and transmission were identified. The evidence were obtained that 518 
sfRNA impairs host mRNA turnover (Moon et al., 2012), inhibits RNAi and miRNA 519 
pathways (Moon et al., 2015b; Esther Schnettler et al., 2012; Schnettler et al., 2014), 520 
supresses type I IFN response in vertebrates (Chang et al., 2013; Schuessler et al., 521 
2012) and Toll pathway in mosquitos (Pompon et al., 2017). In addition, sfRNA was 522 
shown to promote apoptosis of infected cells and virus-induced cytopathic effect (Liu 523 
et al., 2014; Pijlman et al., 2008). These known functions of sfRNA in flavivirus-host 524 
interactions are summarized in Fig 3. In this section we will analyse the current 525 
knowledge on the functional implications of sfRNA in the flavivirus life cycle and 526 
molecular targets of sfRNA. 527 
5.1. sfRNA inhibits host exoribonuclease XRN-1 and dysregulates host 528 
mRNA turnover. 529 
Considering the ability of the secondary structures in the 3’UTR of flaviviruses 530 
to stall XRN-1 (Funk et al., 2010), the effect of sfRNA on XRN-1 activity was among 531 
the first putative functions of sfRNA to be assessed. The competition experiments in 532 
which degradation of labelled reporter RNA by yeast, mammalian and mosquito XRN1 533 
was assessed in the presence of sfRNA or unrelated competitor RNA, demonstrated 534 
that DENV and WNV sfRNA strongly inhibit activity of XRN-1 of any origin. XRN1 535 
suppressor activity of sfRNA was shown to require monophospate at 5’-end and 536 
xrRNA secondary structures (Moon et al., 2012). Taking into account the important 537 
role of XRN1 in maintaining the balance of host RNA transcripts (Nagarajan, 2013), 538 
the effect of sfRNA on mammalian transcriptome was assessed.  It revealed 539 
accumulation of uncapped mRNAs and increased stability of hundreds of host 540 
transcripts in cells infected with sfRNA-producing WNV in comparison to sfRNA-541 
deficient mutant, suggesting that sfRNA strongly impairs mRNA turnover in flavivirus-542 
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infected cells (Moon et al., 2012). It was speculated that inhibition of mRNA decay can 543 
misbalance production of antiviral proteins and pro-inflammatory cytokines that are 544 
predominantly encoded by short-lived mRNAs and thus prevent development of the 545 
functional innate immune response to the virus. Alternatively, excess mRNAs, 546 
including uncapped RNAs was suggested to potentially contribute to the cytopathic 547 
effect associated with sfRNA (Moon et al., 2012). Both these hypotheses can explain 548 
why flaviviruses evolved to inhibit host 5’->3’ RNA decay but require further 549 
experimental validation. In addition, the effect of sfRNA on stability of viral genomic 550 
RNA can also be a potential target for future studies as inhibition of XRN1 by sfRNA 551 
may be required to maintain the balance between genomic RNA and sfRNA in infected 552 
cells.  553 
5.2. sfRNA interferes with generation of siRNAs and miRNAs 554 
Innate immune response to RNA virus infection in invertebrates, including 555 
mosquitoes, relies primarily on RNA interference (RNAi) pathway (Olson and Blair, 556 
2015; Wu et al., 2010). RNAi response involves recognition of double stranded viral 557 
RNA by RNase III-like enzyme Dicer, which cleaves it into 21-nt double-stranded 558 
fragments (Bernstein et al., 2001; Fire et al., 1998). Another important class of Dicer-559 
produced small RNAs is microRNAs (miRNAs) that are 18-24nt in length and, unlike 560 
siRNAs, are encoded by host genes and target endogenous mRNAs, establishing 561 
regulation of gene expression at posttranscriptional level (Lee, 1993). Both small RNA 562 
pathways have been extensively studied in the last two decades and several 563 
comprehensive reviews are available on this subject e.g. (Daugaard and Hansen, 564 
2017; Ha and Kim, 2014; Wilson and Doudna, 2013).  565 
Being generally similar, siRNAs and miRNAs are produced by different 566 
subtypes of Dicer (Lee et al., 2004) and act via different Ago proteins (Schott et al., 567 
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2012). In invertebrates and plants Dicer 1 is responsible for the processing of miRNA 568 
precursors and Dicer 2 is required for siRNA generation (Lee et al., 2004). Vertebrates 569 
are believed to be lacking Dicer 2 and therefore incapable in processing viral RNA 570 
genomes into siRNAs (Cullen, 2014). Thus, siRNA pathway is limited to plants and 571 
invertebrates, whereas miRNAs are produced in all multicellular organisms (Chen and 572 
Rajewsky, 2007). Although RNA viruses have evolved to avoid direct miRNA targeting 573 
of their genomes (Cullen, 2013), flavivirus infection alters expression of numerous 574 
miRNAs in mosquito and vertebrate hosts that have a profound antiviral effect, acting 575 
indirectly via regulation of antiviral genes and host factors required for virus replication 576 
(Ashraf et al., 2016; Chen et al., 2014; Hussain et al., 2011; Kumari et al., 2016; 577 
Ouyang et al., 2016; Slonchak et al., 2015, 2014, Smith et al., 2017, 2012; 578 
Thounaojam et al., 2014; Zhou et al., 2014; Zhu et al., 2015). 579 
Given the important role of siRNAs in antiviral defence in invertebrates, RNA 580 
viruses that infect insects have developed mechanisms to evade or inhibit RNAi 581 
response that rely on viral RNA silencing suppressor (RSS) proteins (Cirimotich et al., 582 
2009; Lu et al., 2005; Nayak et al., 2010). The evidences for RSS activity of flavivirus 583 
proteins are currently conflicting as studies conducted with different flaviviruses 584 
assigned RSS to different viral factors. For instance, the RSS activity was 585 
demonstrated for NS4B and NS3 in DENV2 (Kakumani et al., 2013), whereas capsid 586 
protein was identified as RNAi inhibitor in YFV (Samuel et al., 2016). RSS activity was 587 
also shown for WNV, as cells carrying WNV replicon had reduced ability to develop 588 
shRNA-mediated gene silencing (Schnettler et al., 2012). In addition, decreased 589 
processing of pre-miRNAs into mature miRNAs was demonstrated in WNV-infected 590 
human cells using deep sequencing of small RNAs (Slonchak et al., 2015). However, 591 
RNA-binding activity required for RSS was not detected for any WNV non-structural 592 
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proteins or capsid protein while WNV sfRNA was shown to possess RSS activity 593 
(Schnettler et al., 2012). 594 
The potential RSS activity of sfRNA was suggested based on highly structured 595 
nature of the falviviral 3’UTR containing multiple stem loops and double-stranded 596 
regions that could potentially interact with RNAi processing proteins (Schnettler et al., 597 
2012). The effect of WNV sfRNA on siRNA and miRNA silencing was then assessed 598 
and the ability of sfRNA to inhibit RNAi-silencing of reporter gene was demonstrated in 599 
mosquito and mammalian cells (Moon et al., 2015b; E. Schnettler et al., 2012) and in 600 
mosquitoes (Moon et al., 2015b). The same effect was demonstrated for DENV2 601 
sfRNA in mammalian cells (Moon et al., 2015b). Slight suppression of RNAi-mediated 602 
knockdown of reporter gene was also detected in I. scapularis (tick) cells expressing 603 
LGTV and TBEV sfRNAs (Schnettler et al., 2014). Furthermore, WNV sfRNA was also 604 
shown to interact with Dicer 2 in vitro (E. Schnettler et al., 2012) and to co-precipitate 605 
with Dicer and Ago2 in infected human cells (Moon et al., 2015b). In addition, the 606 
ability of Dicer to process sfRNA into small RNAs was demonstrated in vitro 607 
(Schnettler et al., 2012) and in vivo (Göertz et al., 2016). It was therefore concluded 608 
that sfRNA can act as a sink for the protein components of host RNAi machinery thus 609 
preventing their access to viral genomic RNA and RNA replication intermediates 610 
(Göertz et al., 2016).  611 
Although the body of evidence suggesting inhibitory effect of sfRNA on RNAi 612 
pathway seems solid, the differences in RNAi silencing efficiency between the cells 613 
infected with WT and sfRNA-deficient flaviviruses were relatively mild, 2 to 3 fold or 614 
even less (Moon et al., 2015b; E. Schnettler et al., 2012; Schnettler et al., 2014). 615 
Moreover, generation of abundant virus-derived siRNA was detected in mosquito cells 616 
infected with sfRNA-producing wild type WNV (Göertz et al., 2016) and an up-617 
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regulation of certain antiviral miRNAs was reported in WNV-infected human cells 618 
(Slonchak et al., 2015; Smith et al., 2012) indicating that host cells can develop 619 
functional RNAi and miRNA response regardless of the presence of sfRNA. In 620 
addition, WNV deficient in production of sfRNA-2 showed no difference in replication 621 
comparing to WT virus in either RNAi-competent or RNAi-deficient mosquito cell lines 622 
(Göertz et al., 2016). Although replication of the WNV mutant with impaired production 623 
of sfRNA-1 and sfRNA-2 was highly compromised comparing to WT in RNAi 624 
competent cell line (Göertz et al., 2016), there was no evidence that this difference 625 
was related to the effect of sfRNA on RNAi pathway as replication of the same viruses 626 
in RNAi-deficient cells was not assessed. Therefore, it is currently unclear if RSS 627 
activity of sfRNA is potent enough to determine the evasion of RNAi response by 628 
flaviviruses. Further side by side comparison of the wild type and mutant flavivirus 629 
deficient in production of all sfRNA species in RNAi- competent and RNAi-deficient cell 630 
lines as well as quantification of virus-derived siRNAs produced in infection with both 631 
viruses should clarify the biological relevance of RSS activity exhibited by sfRNAs.    632 
5.3. sfRNA inhibits RNAi-independent Toll antiviral pathway in mosquitos 633 
Intriguingly, recent study demonstrated that sfRNA-1 of WNV was critical for 634 
replication of WNV in mosquito midgut and crossing the midgut barrier, while it did not 635 
affect virus replication in either RNAi-competent or RNAi-deficient mosquito cell lines. 636 
(Göertz et al., 2016). This indicates that sfRNA-1 could also inhibit RNAi-independent 637 
antiviral pathways in mosquitoes. RNAi-independent antiviral defence in mosquitoes 638 
relies on Toll, IMD and Jack-STAT pathways (reviewed in (Sim et al., 2014) and on 639 
recently characterized Vago pathway (Paradkar et al., 2014, 2012). 640 
Toll pathway is somewhat similar to NF-kB pathway of vertebrates and was 641 
shown to be activated in DENV-infected Aedes sp mosquitoes (Xi et al., 2008). It 642 
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involves detection of pathogen-associated molecular patterns (PAMPs) by pattern 643 
recognition receptors (PRRs) PGRP-SA and PGRP-SD and subsequent signalling 644 
cascade which results in translocation of transcription factor Rel1 into the nucleus and 645 
activation of antiviral genes (Moon et al., 2015a). The IMD pathway was also shown to 646 
be involved in protection against DENV in mosquito cells (Sim and Dimopoulos, 2010) 647 
and functionally resembles cJun/JNK pathway of the vertebrates (Myllymaki et al., 648 
2014). The Janus kinase/signal transducers and activators of transcription – signal 649 
transducer and activator of transcription (JAK-STAT) pathway in mosquitos is similar 650 
to interferon-induced JAK-STAT-signalling of vertebrates and has been shown to 651 
mediate the mosquito immune response to DENV but not ZIKV (Jupatanakul et al., 652 
2017; Souza-Neto et al., 2009). Vago pathway acts in conjunction with JAK-STAT 653 
pathway and represents mosquito equivalent of RIG-I/MDA-5 signalling pathway. Vago 654 
pathway involves sensing of dsRNA by Dicer-2 and results in release of Vago peptide. 655 
Secreted Vago binds to the specific receptor and activates JAK-STAT pathway in 656 
bystander cells similar to IFN in vertebrates. This pathway has been shown to 657 
contribute to innate immune response against WNV in Culex mosquitos (Paradkar et 658 
al., 2012). 659 
Recently, the first study adressing the effect of sfRNA on RNAi-independent 660 
antiviral pathways in mosquitoes was reported (Pompon et al., 2017). In this study 661 
mosquitos were infected with PR6452 and PR315022 strains of DENV2 that have low 662 
and high production of sfRNA per a copy of viral genome, respectively. The expression 663 
of innate immunity genes in salivary glands, bodies and carcases of infected 664 
mosquitos was then compared to those produced in uninfected mosquitoes. Infection 665 
with DENV2 strain, which produced high amount of sfRNA was shown to prevent 666 
activation of Toll-pathway component Rel1a and to inhibit expression of another Toll-667 
pathway effector CecG in mosquito salivary glands, whereas increased expression of 668 
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both proteins was observed upon infection with the virus that generated small amount 669 
of sfRNA. The results were futher validated using chimeric viruses in which 5’UTR and 670 
coding sequence of PR6452 was combined with the 3’UTR of PR315022 and vice 671 
versa. The results showed that inhibition of Toll pathway-associated genes was 672 
caused by the 3’UTR sequence and not by the coding region. However, no significant 673 
correlaton between sfRNA production and expression of genes related to IMD, JAK-674 
STAT and Vago pathways was observed in this study (Pompon et al., 2017).  675 
These recent findings suggest that DENV sfRNA inhibits Toll pathway in 676 
infected Aedes sp mosquitos, however studies with other flaviviruses that replicate in 677 
different mosquitoe species need to be performed to determine if this function of 678 
sfRNA is unique to DENV or universall for all flaviviruses. In addition, it would be 679 
interesting to use flavivirus mutant completely deficient in sfRNA and compare the 680 
expression of wider range of genes related to IMD, JAK-STAT and Vago signalling. 681 
Modern methods of high-throughpout transcriptome and proteome profiling make this 682 
task relatively easy to achive and the reslts should give us furher insights into the 683 
effect of sfRNA on RNAi-independent innate immunity in mosquitos. 684 
5.4. sfRNA inhibits type I IFN response in vertebrates 685 
Within vertebrate cells flaviviruses encounter potent antiviral activity of the type 686 
1 interferon (IFN) innate immune response, which has been a subject to a few 687 
comprehensive reviews e.g. (Cumberworth et al., 2017; Miorin et al., 2017). Briefly, 688 
IFN response begins with the detection of a viral PAMPs by a cellular pattern 689 
recognition receptor (PRR), that triggers a signalling cascade, which activates 690 
transcription factors known as IFN regulatory factors (IRFs) and NF-ΚB (Quicke & 691 
Suthar, 2013). These transcription factors drive the expression of pro-inflammatory 692 
cytokines including type I IFN (Quicke & Suthar, 2013). Once produced and secreted, 693 
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type I IFNs bind to the IFN-α/β receptor (IFNAR) and activate JAK-STAT signalling 694 
cascade, which leads to expression of >300 IFN-stimulated antiviral genes (ISGs) 695 
(reviewed in (Randall and Goodbourn, 2008)). 696 
To enable replication in vertebrate hosts flaviviruses have evolved multiple 697 
strategies to evade and inhibit type I IFN response, including inhibition of RNA sensing 698 
by PRRs, signal transduction to IRFs, and JAK-STAT cascade (reviewed in 699 
(Cumberworth et al., 2017; Diamond, 2009). Inhibitory activity against IFN response 700 
have been demonstrated for viral non-structural proteins NS5  (Best, 2017; Grant et 701 
al., 2016; Laurent-Rolle et al., 2010), NS4B (Muñoz-jordán et al., 2005; Wang et al., 702 
2005), NS3 (Setoh et al., 2017, 2015; Wang et al., 2005), NS2B (Aguirre et al., 2012; 703 
Wang et al., 2005), NS2A (Liu et al., 2004; Setoh et al., 2015; Wang et al., 2005), 704 
NS1(Xia et al., 2018) and for sfRNA (Bidet et al., 2014; Chang et al., 2013; Donald et 705 
al., 2016; Manokaran et al., 2015; Schuessler et al., 2012). 706 
The interferon antagonist activity of sfRNA was first suggested based on 707 
observation that although sfRNA-deficient WNV mutant replicated to lower titres and 708 
did not cause mortality in IFN-competent WT mice, both sfRNA-deficient and sfRNA-709 
competent viruses, exhibited no difference in replication in IFN-deficient vertebrate cell 710 
lines e.g. Vero-76 and BHK-21(Pijlman et al., 2008). To address the possible role of 711 
sfRNA in evasion of type I IFN response, replication of WT and sfRNA-deficient WNV 712 
mutant was assessed in IFN-competent wild type mouse embryonic fibroblasts (MEF) 713 
and in MEFs deficient in transcription factors IRF3 and IRF7. In this experiment similar 714 
replication of WT and sfRNA-deficient mutant viruses was observed in IRF-3/7-715 
deficient MEFs, whereas replication of the sfRNA-deficient mutant virus was 716 
significantly reduced in IRF-3/7-competent cells compared to that of WT virus 717 
(Schuessler et al., 2012). Moreover, replication of sfRNA-deficient WNV in IRF3/7-718 
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deficeint MEFs was reduced drastically and in dose-dependent manner in response to 719 
the addition of exogenous IFN-alpha, whereas the addition of IFN-alpha had lesser 720 
effect on the replication of WT WNV. In addition, replication and neurovirulence of 721 
sfRNA-deficient WNV was partially restored in mice lacking functional IRF-3/7 or 722 
IFNAR (Schuessler et al., 2012). These experiments strongly indicated that sfRNA 723 
inhibits IFN signalling and that this inhibition is happening downstream of IFN sensing 724 
by IFNAR. 725 
Moreover, it was shown that transfection of in vitro transcribed 5’-726 
monphosphate WNV  3’UTR RNA was able to rescue replication of Semliki forest virus 727 
in IFN-treated cells, whereas the effect was not observed if mutated 3’UTR RNA 728 
unable to be processed into sfRNA was transfected (Schuessler et al., 2012). This 729 
indicates that sfRNA has a direct inhibitory effect on IFN signalling. Furthermore, other 730 
studies showed that transfection of in vitro transcribed JEV sfRNA was shown to 731 
reduce phosphorylation and nuclear translocation of IRF3 and IRF7 in JEV-infected 732 
cells and led to ~2-fold decease in the expression of a reporter gene from IFN-β 733 
promoter (Chang et al., 2013). Although JEV sfRNA findings suggests the additional 734 
inhibitory effect of sfRNA on the IFN-pathway upstream of IFN secretion/sensing, the 735 
performed experiments had some serious limitations. The in vitro transcribed JEV 736 
sfRNA contained 5’-triphosphates, which is different from 5’-monophosphate-737 
containing sfRNA produced in infected cells. As 5’-triphosphates can be recognised by 738 
PRRs as a PAMP, this can trigger the whole range of antiviral responses and lead to 739 
rapid elimination of viral infection, thus producing the results that cannot be properly 740 
interpreted. The effect of 5’-monophosphorylated sfRNA and of the infection with 741 
sfRNA-competent and sfRNA-deficient flaviviruses on phosphorylation and nuclear 742 
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translocation of IRFs should be assessed to confirm the ability of sfRNA to suppress 743 
signalling factors upstream of IFN production.  744 
More recently the inhibitory effect of sfRNA on type I IFN response was also 745 
demonstrated for DENV2 (Manokaran et al., 2015) and ZIKV infection (Donald et al., 746 
2016).  In particularly, sfRNA production and expression of IFN-β was compared in 747 
infection of human hepatocellular carcinoma cells with two groups (clades) of DENV2 748 
strains from Puerto Rico - pre-epidemic clade PR-1 and epidemic clade PR-2B strains. 749 
Epidemic strains were shown to contain mutations in the 3’UTR that resulted in 750 
production of higher amounts of sfRNA per copy of genomic RNA than pre-epidemic 751 
strains. Although both clades of DENV replicated at similar levels at later time points, 752 
epidemic strains induced weaker production of IFN-β and replicated similarly in IRF3-753 
deficient cells while replication of pre-epidemic strains was increased in IRF3-deficent 754 
cells.  In addition, transfection of in vitro transcribed PR-2B sfRNA together with IFN-755 
response stimulator polyIC resulted in reduced expression of IFN-β compared to 756 
transfection of polyIC with pre-epidemic strain sfRNA. Notably, transfection with any 757 
DENV sfRNA reduced IFN-β expression compared to transfection with polyIC alone, or 758 
with nonspecific RNA of the same size, thus further confirming IFN antagonist activity 759 
of DENV sfRNA (Manokaran et al., 2015). Moreover, expression of DENV sfRNA from 760 
plasmid DNA was shown to reduce by ~2-fold the expression on reporter gene 761 
controlled by IFN-β promoter in polyIC-stimulated cells. Similar effect was also 762 
observed if ZIKV sfRNA was expressed from plasmid DNA in the same system, 763 
providing the evidence for IFN antagonist activity of ZIKV sfRNA (Donald et al., 2016). 764 
Several attempts have been also made to identify the molecular targets of 765 
sfRNA in RNA-sensing and IFN-signalling pathways. RNA binding proteins (RBPs) 766 
G3BP1, G3BP2 and CAPRIN1 were identified as novel mediators of IFN response 767 
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against DENV2. These proteins were found to be required for translation of mRNAs 768 
encoding for ISGs such as PKR and IFITM2. Intriguingly, sfRNA produced in DENV2 769 
infection was shown to co-localize with G3BP1, G3BP2 and CAPRIN1 by 770 
immunofluorescent analysis and RNA FISH, and to co-precipitate with these proteins 771 
in antibody pull downs. SLII was found to be required for interactions of DENV2 sfRNA 772 
with G3BP1, G3BP2 and CAPRIN1 and mutated in vitro transcribed sfRNA and 773 
DENV2 replicons lacking binding site were used to assess functional outcomes of 774 
sfRNA-RBPs interactions. Binding of DENV2 sfRNA to G3BP1, G3BP2 and CAPRIN1 775 
was shown to inhibit translation of selected ISGs and to protect DENV2 replicons from 776 
antiviral activity of IFN-β (Bidet et al., 2014). This study was the first to link IFN 777 
antagonist effect of sfRNA with the specific molecular components of the IFN response 778 
pathway. Later, DENV2 sfRNA was also shown to interact with the ubiquitin ligase 779 
triptate motif protein 25 (TRIM25) and to inhibit deubiquitination of TRIM25 and 780 
subsequent ubiquitination of RIG-I, ultimately leading to inhibition of viral RNA sensing 781 
by RIG-I. More efficient binding of sfRNA to TRIM25 was linked to the weaker IFN 782 
response to epidemic PR-2B strains of DENV2 and was proposed to be responsible 783 
for the increased fitness of epidemic strains (Manokaran et al., 2015). Interestingly, the 784 
inhibitory effect of sfRNA on RIG-I pathway was also demonstrated by the experiment 785 
in which the expression of the reporter gene from IFN-β promoter was assessed in 786 
cells co-transfected with ZIKV or DENV sfRNA and the reporter plasmid upon 787 
treatment with RIG-I agonist. Cells expressing either of these sfRNAs showed ~2-fold 788 
lower IFN-β promoter activity than those expressing unrelated control RNA (Donald et 789 
al., 2016). 790 
Thus, so far TRIM25 has been identified as molecular target of sfRNA upstream 791 
of IFN-β production while G3BP1/2 and CAPRIN1 have been identified as molecular 792 
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targets of sfRNA downstream of IFN-α/β signalling. However, it is likely that this is only 793 
the tip of the iceberg and we are still far from identifying complete map of molecular 794 
interactions that mediate IFN antagonist effect of sfRNA. First of all, binding of 795 
G3BP1/2 and CAPRIN1 was shown to occur only with sfRNA from clinical isolate of 796 
DENV2, and not for sfRNAs from DENV3, YF vaccine strain 17D or Kunjin strain of 797 
WNV (Bidet et al., 2014). Therefore, it is premature to extrapolate these findings to 798 
other flaviviruses. In addition, binding of TRIM25 to sfRNA was only assessed for 799 
DENV2 and was shown to be increased upon mutations in the 3’UTR specific to 800 
epidemic strain of DENV2 from Puerto Rico (Manokaran et al., 2015). The sequence 801 
of 3’UTRs is highly variable between flaviviruses although their structural organisation 802 
is rather conserved (Clarke et al., 2015; Göertz and Pijlman, 2015; Roby et al., 2014). 803 
Thus, considering high variability of the 3’UTR sequence and large effect of point 804 
mutations in the DENV2 3’UTR on TRIM25 binding it seems rather unlikely that this 805 
interaction will also occur with sfRNAs from other flaviviruses. In summary, a large 806 
body of evidence has been accumulated to date demonstrating the inhibitory effect of 807 
sfRNA on IFN response pathway, both upstream and downstream of IFN production, 808 
however, further studies are clearly required to identify molecular targets in IFN 809 
response pathway for sfRNAs of different flaviviruses.   810 
5.5. sfRNA is required for viral cytopathicity and pathogenicity. 811 
Infection with Flaviviruses has been shown to induce cytopathic effect in 812 
cultured cells and promote apoptosis via activation of several signalling cascades such 813 
as endoplasmic reticulum stress response and AKT/PI3K pathway (reviewed in 814 
(Okamoto et al., 2017)). It is generally believed that apoptosis of the infected cells is 815 
the part of host antiviral response aimed to clear the infection. However, the real role 816 
of apoptosis in flavivirus infection can be more complex than that as pro-apoptotic 817 
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activity has been reported for viral structural proteins C (Netsawang et al., 2010), M 818 
(Catteau et al., 2003) and E (Prikhod’ko et al., 2001) and non-structural NS2A (Liu et 819 
al., 2006; Melian et al., 2013), NS2B (Yang et al., 2009) and NS3 (Shafee and 820 
AbuBakar, 2003)), suggesting that induction of apoptosis can be also required for viral 821 
propagation.  822 
Intriguingly, production of sfRNA appears to be paramount for flavivirus-induced 823 
cytopathic effect. Mutants of WNV (Pijlman et al., 2008) and DENV (Liu et al., 2014) 824 
deficient in generation of sfRNA-1 have been shown to have drastically reduced ability 825 
to form plaques on Vero and BHK-21 cells, respectively. Crystal violate staining and 826 
lactate dehydrogenase secretion assays further confirmed reduced cytopathicity of 827 
sfRNA-deficient WNV by demonstrating that at 6 days post infection with 100% 828 
infection rate it resulted in death of only 10% of cells versus 70% caused by sfRNA-829 
competent virus. Complementation with sfRNA produced in trans from the plasmid 830 
partially rescued plaque-forming and cytopathic properties of sfRNA-deficient WNV 831 
and DENV mutants, providing strong indication for the requirement of sfRNA for virus-832 
induced cytopathicity (Liu et al., 2014; Pijlman et al., 2008). In cells infected with 833 
sfRNA-deficient DENV reduced cleavage of caspase 3 and of Annexin V translocation 834 
of to the cell surface compared to the WT DENV infected cells were observed, 835 
suggesting that sfRNA facilitates activation of caspase 3 - dependent apoptotic 836 
pathways. This was accompanied by high phosphorylation of Akt and high expression 837 
of anti-apoptotic protein Bcl-2 at the later time points post infection, whereas WT 838 
DENV infection resulted in decreased expression of Bcl-2 and no detected 839 
phosphorylated Akt after 48h post infection (Liu et al., 2014). These data indicate that 840 
sfRNA may trigger apoptosis by suppressing Bcl-2, however the biological relevance 841 
of this effect and its role in viral pathogenesis is yet to be determined. 842 
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Furthermore, sfRNA was shown to be required for WNV-induced 843 
neuropathogenicity in vertebrates as all mice infected with sfRNA-deficient virus failed 844 
to develop symptoms of encephalitis and survived the infection, which was 100% 845 
lethal in animals challenged with sfRNA-competent virus.  Both groups of animals had 846 
similar viral loads in the brain, which indicates that lack of mortality in mice infected 847 
with sfRNA-deficient virus was not due to its inability to penetrate the blood-brain 848 
barrier and replicate in the brain (Pijlman et al., 2008). The likely explanation for the 849 
lack of neuropathogenicity associated with the loss of sfRNA is the inability of the virus 850 
to induce apoptosis and kill infected brain cells. 851 
 852 
6. Conclusions and future directions 853 
Generation of highly structured nuclease resistant noncoding RNA via halting 854 
digestion of viral genomic RNA by the host exoribonuclease XRN-1 is the evolutionary 855 
conserved process within flavivirus genus. This indicates for a crucial role of sfRNA in 856 
propagation of flaviviruses in all types of hosts. Despite conservation of sfRNA 857 
biogenesis by XRN-1, different taxonomical groups of flaviviruses employ somewhat 858 
dissimilar structural determinants for XRN-1 resistance (Fig 2A). Structural similarity of 859 
XRN-1-resistant elements generally correlates with evolutional relationships between 860 
flaviviruses. xrRNAs of MBFVs share structural but not sequence similarity with those 861 
of ISFs, while TBFVs have xrRNAs more similar to phylogenetically related NKVFs. 862 
This suggests that the ability to stall XRN-1 for generation of sfRNA appeared very 863 
early in evolution of flaviviruses before current taxonomic groups within the genus had 864 
diverged. Further evolution of XRN-1 resistance probably dictated accumulation of 865 
changes in the structure of xrRNAs related to adaptation for replication in different 866 
hosts. Why different structures of xrRNAs were selected in MBFVs/ISFs and 867 
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TBFVs/NKVFVs groups and whether these differences are in fact the result of 868 
adaptation to different hosts remain to be elucidated. 869 
sfRNA also appears to determine microevolution of flaviviruses as accumulation 870 
of mutations in 3’UTR that shift the balance between genomic RNA and sfRNA have 871 
been reported to contribute to the emergence of new epidemic strains of DENV. In the 872 
future this property of flaviviruses can potentially be used for predicting flavivirus 873 
outbreaks but it will definitely require more studies on the relationships between virus 874 
fitness and sfRNA generation for different flaviviruses. 875 
Highly conserved production of sfRNA is most likely determined by its ability to 876 
inhibit major antiviral pathways in arthropods and vertebrates - RNAi and type I IFN 877 
response, respectively. sfRNA was shown to be a dicer substrate and believed to 878 
saturate the enzyme thus preventing its access to viral genomic RNA. The molecular 879 
mechanisms that mediate IFN-antagonist activity of sfRNA, however, remain elusive. 880 
DENV sfRNA interactions with RIG-I cofactor TRIM25 and translational activators of 881 
ISGs have been reported but whether these interactions can be extrapolated to 882 
sfRNAs of other flaviviruses remains unclear. Identification of other molecular targets 883 
of sfRNA in IFN response pathway should be a priority direction in the field as it could 884 
produce significant new knowledge required for full understanding of the critical role of 885 
sfRNA in the flavivirus life cycle. Considering low sequence and high structural 886 
conservation of flavivirus 3’UTRs, proteins that recognise structural (stem loops and 887 
dumb bells) or biochemical (5’-monophosphate) motifs will be the most likely sfRNA-888 
interacting partners of functional importance. In addition, the effect of sfRNA on RNAi-889 
independent antiviral pathways in arthropods can be another attractive target to look at 890 
in the future. Currently the inhibitory effect of DENV sfRNA on Toll-pathway has been 891 
demonstrated in a single study and testing if sfRNA can modulate additional pathways 892 
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of mosquito antiviral response may advance our understanding of the mechanisms by 893 
which sfRNA facilitates replication of flaviviruses in invertebrate host. 894 
Finally, the requirement of sfRNA for virus-induced apoptosis and 895 
neuropathogenicity may open a new avenue in the design of the attenuated vaccines. 896 
If sfRNA-deficient mutant flaviviruses prove unable to induce encephalitis in nonhuman 897 
primates while retaining their immunogenicity, similar to what is observed in mice 898 
(Funk et al, 2010), they can be considered as a novel promising flavivirus vaccine 899 
platform. 900 
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 906 
Figures legends 907 
Fig 1. Subgenomic flaviviral RNA is produced as a result of incomplete 908 
degradation of genomic RNA by host enzyme XRN-1. (A) Schematics of the 909 
flavivirus (DENV2) genome organization. (B) Schematic representation of sfRNA 910 
biogenesis via XRN-1 digestion. The schematics shows secondary structure of 911 
flavivirus (DENV2) 3’UTR with stem loops (SL) dumb bells (DB), short hairpin and 3’-912 
terminal stem loop (3’SL); pseudoknots (PK) and sfRNA start sites. The model is 913 
based on SHAPE reactivity data from (Chapman et al., 2014a)  (C) Northern blot 914 
demonstrating generation of several sfRNA species in DENV2-infected mosquito cells 915 
due to stalling of XRN-1 at different halt sites. (B) and (C) are reproduced with 916 
permission from (Filomatori et al., 2017). 917 
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Fig.2 Structural determinants of sfRNA biogenesis. (A) XRN-1 resistant structures 918 
formed by stem loops (SL) and dumb bells (DB) in the 3’UTRs of representative 919 
flaviviruses from different taxonomical groups of Flavivirus genus. Dendrogram shows 920 
phylogenetic relationships between flavivirus clades. Red lines indicate pseudoknots, 921 
orange lines show base pairs (internal small pseudoknots), blue lines show base triple 922 
and green lines show noncanonical base pairing. sfRNA start sites (where known) are 923 
indicated with a blue arrow. (B) Tertiary structure of xrRNA from 3’UTR of ZIKV. 924 
Different elements of RNA structures are color-coded. Bases holding the 5’-end inside 925 
the circle are shown in red. (C) Model of interactions between XRN-1 and xrRNA of 926 
ZIKV. (B) and (C) are reproduced with permission and minor modifications from 927 
(Akiyama et al., 2016). 928 
Fig. 3. Functions of sfRNA in arthropod and vertebrate hosts. sfRNA inhibits XRN-929 
1 and Dicer in both hosts, causing disruption of mRNA decay and siRNA/miRNA 930 
production, respectively. In vertebrates sfRNA inhibits IFN-α/β response and induces 931 
apoptosis. Inhibitory effect of sfRNA on IFN-α/β response is in part mediated by sfRNA 932 
binding to TRIM25 and to CAPRIN1/G3BP1/2 and inhibiting their functions in IFN 933 
induction and IFN signalling, respectively. In mosquitoes, sfRNA inhibits expression of 934 
Toll-pathway components CecG and Rel1a and supresses Toll-signalling in addition to 935 
inhibiting RNAi response. 936 
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• sfRNAa are produced via incomplete digestion of flaviviral genomic RNA by XRN-1. 
• RNA elements in 3’UTRs that form a 3-way junctions (xrRNAs) and pseudoknots are 
required to stall XRN-1 and produce sfRNAs. 
• Generation of sfRNAs is highly conserved amongst all flaviviruses, whereas the 
structure of xrRNAs varies. 
• xrRNA structures are duplicated in some flaviviruses resulting in the production of up 
to four sfRNA species of different sizes 
• Different sfRNA species may be required for adaptation of some flaviviruses to 
replication in arthropod or vertebrate hosts 
• sfRNA is required for pathogenesis of flaviviruses in vertebrates and transmission by 
arthropods 
• sfRNA inhibits RNAi response and Toll pathway in arthropods and type I interferon 
IFN response in vertebrates. 
 
